Effect of sodium –glucose cotransporter 2 inhibitors on insulin resistance; a systematic review and meta-analysis
ConclusionSGLT2Is, particularly dapagliflozin, could increase IS. These results need to be consolidated by further studies.
Source: Acta Diabetologica - Category: Endocrinology Source Type: research
More News: Clinical Trials | Dapagliflozin | Databases & Libraries | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Empagliflozin | Endocrinology | Fortamet | Forxiga | Insulin | Jardiance | Metformin | Science | Sodium | Study